Skip to main content

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
596,837
Value
$150.2M
% of portfolio
2.0%
Quarters held
22
Since Q1 2021
Holdings of ABBV by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026596,837$150.2M2.0%−4,875−0.8%ReducedHolders
Q1 2026601,712$130.9M1.9%+8,859+1.5%AddedHolders
Q4 2025592,853$135.5M1.9%+423+0.1%AddedHolders
Q3 2025592,430$137.2M2.0%−3,079−0.5%ReducedHolders
Q2 2025595,509$110.5M1.8%−16,246−2.7%ReducedHolders
Q1 2025611,755$128.2M2.2%−3,948−0.6%ReducedHolders
Q4 2024615,703$109.4M1.9%+37,287+6.4%AddedHolders
Q3 2024578,416$114.2M2.0%+8,585+1.5%AddedHolders
Q2 2024569,831$97.7M1.8%+2620.0%AddedHolders
Q1 2024569,569$103.7M1.9%+986+0.2%AddedHolders
Q4 2023568,583$88.1M1.8%+25,316+4.7%AddedHolders
Q3 2023543,267$81.0M1.9%+5,972+1.1%AddedHolders
Q2 2023537,295$72.4M1.6%+12,553+2.4%AddedHolders
Q1 2023524,742$83.6M2.0%+10,405+2.0%AddedHolders
Q4 2022514,337$83.1M2.1%+10,982+2.2%AddedHolders
Q3 2022503,355$67.6M1.9%+11,684+2.4%AddedHolders
Q2 2022491,671$75.3M1.9%−6,436−1.3%ReducedHolders
Q1 2022498,107$80.7M1.8%+18,814+3.9%AddedHolders
Q4 2021479,293$64.9M1.4%−25,416−5.0%ReducedHolders
Q3 2021504,709$54.4M1.3%−14,716−2.8%ReducedHolders
Q2 2021519,425$58.5M1.4%+28,810+5.9%AddedHolders
Q1 2021490,615$53.1M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.